(Q34184361)

31 July 2017

1 reference

title

Lymphatic targeting with nanoparticulate system (English)

1 reference

31 July 2017

1 reference

Nishioka Y

1

1 reference

PubMed ID

11251245

31 July 2017

Yoshino H

series ordinal

2

1 reference

PubMed ID

11251245

31 July 2017

language of work or name

English

0 references

publication date

1 March 2001

1 reference

31 July 2017

10

1 reference

Advanced Drug Delivery Reviews

inferred from page(s)

published in

1 reference

31 July 2017

47

1 reference

31 July 2017

1

1 reference

31 July 2017

55-64

1 reference

Studies on pharmaceutical modification of anticancer agents. I. Enhancement of lymphatic transport of mitomycin C by parenteral emulsions

31 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900121-6

7 January 2021

Studies on pharmaceutical modification of anticancer agents. II. Enhanced delivery of bleomycin into lymph by emulsions and drying emulsions

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900121-6

7 January 2021

Lymphatic transport of liposome-encapsulated agents: effects of liposome size following intraperitoneal administration

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900121-6

7 January 2021

Evaluation of water in oil and microsphere in oil emulsions as a specific delivery system of 5-fluorouracil into lymphatics

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900121-6

7 January 2021

A lymphotropic colloidal carrier system for diethylcarbamazine: preparation and performance evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900121-6

7 January 2021

Carrier activity of sonicated small liposomes containing melphalan to regional lymph nodes of rats

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900121-6

7 January 2021

Lymphatic uptake and biodistribution of liposomes after subcutaneous injection. II. Influence of liposomal size, lipid compostion and lipid dose

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900121-6

7 January 2021

Lymphatic uptake and biodistribution of liposomes after subcutaneous injection: III. Influence of surface modification with poly(ethyleneglycol)

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900121-6

7 January 2021

Lymphatic delivery and pharmacokinetics of methotrexate after intramuscular injection of differently charged liposome-entrapped methotrexate to rats

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900121-6

7 January 2021

Morphological observations on the fate of liposomes in the regional lymph nodes after footpad injection into rats

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900121-6

7 January 2021

Lymphatic uptake and biodistribution of liposomes after subcutaneous injection . IV. Fate of liposomes in regional lymph nodes

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900121-6

7 January 2021

Immunoliposomes and PEGylated immunoliposomes: possible use for targeted delivery of imaging agents

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900121-6

7 January 2021

Chemotherapy targeting regional lymph nodes by gastric submucosal injection of liposomal adriamycin in patients with gastric carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900121-6

7 January 2021

Preoperative lymph-node staining with liposomes containing patent blue violet. A clinical case report.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900121-6

7 January 2021

In vitro evaluation of polymerized liposomes as an oral drug delivery system

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900121-6

7 January 2021

Lymphatic targeting of polymeric nanoparticles after intraperitoneal administration in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900121-6

7 January 2021

Lymph node localisation of biodegradable nanospheres surface modified with poloxamer and poloxamine block co-polymers

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900121-6

7 January 2021

Preparation of biodegradable, surface engineered PLGA nanospheres with enhanced lymphatic drainage and lymph node uptake

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900121-6

7 January 2021

Development of superparamagnetic nanoparticles for MRI: effect of particle size, charge and surface nature on biodistribution

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900121-6

7 January 2021

Solid lipid nanoparticles in lymph and plasma after duodenal administration to rats

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900121-6

7 January 2021

Selective drug delivery to peri-tumoral region and regional lymphatics by local injection of aclarubicin adsorbed on activated carbon particles in patients with breast cancer--a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900121-6

7 January 2021

10.1016/S0169-409X(00)00121-6

Identifiers

DOI

1 reference

31 July 2017

1 reference

PubMed ID

11251245